World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
38867
World Ranking
9563
National Ranking
4928

John Mendelsohn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John Mendelsohn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 234 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John Mendelsohn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John Mendelsohn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2014 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1997 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

John Mendelsohn was affiliated with The University of Texas at Austin in the United States. Their research primarily focused on environmental science, with an emphasis on ecology and related subfields.

The main fields of study encompassed:

  • Environmental Science

Their subfields of research included:

  • Ecology
  • Nature and Landscape Conservation
  • Ecological Modeling
  • Management, Monitoring, Policy and Law
  • Ecology, Evolution, Behavior and Systematics

The scientist's work covered several topics, notably:

  • Wildlife Ecology and Conservation
  • Ecology and Vegetation Dynamics Studies
  • Species Distribution and Climate Change
  • Avian ecology and behavior
  • Rangeland Management and Livestock Ecology
  • Animal Behavior and Reproduction
  • Aquatic Ecosystems and Biodiversity

Key publications that reflect the scope of their research included:

  • "Africa's drylands in a changing world: Challenges for wildlife conservation under climate and land-use changes in the Greater Etosha Landscape," 2022, published in Global Ecology and Conservation
  • "Understanding continent-wide variation in vulture ranging behavior to assess feasibility of Vulture Safe Zones in Africa: Challenges and possibilities," 2022, published in Biological Conservation
  • "A utilization distribution for the global population of Cape Vultures (Gypscoprotheres) to guide wind energy development," 2023, published in Ecological Applications
  • "Quantifying spatial ignorance in the effort to collect terrestrial fauna in Namibia, Africa," 2023, published in Ecological Indicators
  • "Double-brooding in Southern Yellow-billed Hornbills Tockus leucomelas," 2021, published in Ostrich

The frequent co-authors who collaborated with Mendelsohn included:

  • Monique MacKenzie
  • Nina Farwig
  • Ryno Kemp
  • Sascha Rösner
  • Dana G. Schabo

Their research was published in venues such as:

  • Global Ecology and Conservation
  • Biological Conservation
  • Ecological Applications
  • Ecological Indicators
  • Ostrich

Mendelsohn was a recipient of several distinctions including:

  • Fellow of the American Association for the Advancement of Science (AAAS), 2014
  • Member of the National Academy of Medicine (NAM), 1997
  • Member of the Association of American Physicians

Best Publications

  • Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

    J. Baselga;Debasish Tripathy;J. Mendelsohn;S. Baughman

  • The EGF receptor family as targets for cancer therapy.

    John Mendelsohn;Jose Baselga

  • Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer

    John Mendelsohn;Jose Baselga

  • Recombinant Humanized anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin Against HER2/neu Overexpressing Human Breast Cancer Xenografts

    Jose Baselga;Larry Norton;Joan Albanell;Young Mee Kim

  • Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

    Neil I. Goldstein;Marie Prewett;Kazys Zuklys;Patricia Rockwell

  • The Molecular Basis of Cancer

    John Mendelsohn;Peter M. Howley;Mark A. Israel;Joe W. Gray

  • Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin

    Jose Baselga;D. Pfister;M. R. Cooper;R. Cohen

  • Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

    T. Kawamoto;J. D. Sato;A. Le;J. Polikoff

  • Epidermal Growth Factor Receptor Targeting in Cancer

    John Mendelsohn;Jose Baselga

  • Growth Inhibition of Human Tumor Cells in Athymic Mice by Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies

    H Masui;T Kawamoto;J D Sato;B Wolf

  • Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.

    J. D. Sato;T. Kawamoto;A. D. Le;J. Mendelsohn

  • Antitumor Effect of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies plus cis-Diamminedichloroplatinum on Well Established A431 Cell Xenografts

    Zhen Fan;Jose Baselga;Hideo Masui;John Mendelsohn

  • In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.

    Luka Milas;Kathy Mason;Nancy Hunter;Sven Petersen

  • HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells

    Christiane Knuefermann;Yang Lu;Bolin Liu;Weidong Jin

  • Targeting the epidermal growth factor receptor for cancer therapy

    John Mendelsohn

  • Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.

    Jose Baselga;Larry Norton;Hideo Masui;Atanasio Pandiella

  • Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.

    Xipu Wu;Zhen Fan;Hideo Masui;Neal Rosen

  • Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

    Maria Schwaederle;Melissa Zhao;J. Jack Lee;Alexander M. Eggermont

  • Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.

    Jordi Rodon;Jean Charles Soria;Raanan Berger;Wilson H. Miller

  • Antitumor Effect of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies plus cis-Diamminedichloroplatinum on Well Established

    Zhen Fan;Jose Baselga;Hideo Masui;John Mendelsohn

Frequent Co-Authors

Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Giampaolo Tortora
Giampaolo Tortora University of Verona
Peter M. Howley
Peter M. Howley Harvard Medical School
Rakesh Kumar
Rakesh Kumar The University of Texas MD Anderson Cancer Center
Mahitosh Mandal
Mahitosh Mandal Indian Institute of Technology Kharagpur
Craig B. Thompson
Craig B. Thompson Memorial Sloan Kettering Cancer Center
Razelle Kurzrock
Razelle Kurzrock Medical College of Wisconsin
Joe W. Gray
Joe W. Gray Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean pursuing a traditional MD. The healthcare sector offers diverse online degree options—many designed to fit around busy lifestyles and financial needs.

One popular entry point is medical billing and coding financial aid programs, which make it easier to get started in healthcare administration with reduced tuition costs. For those seeking clinical roles, there are nursing school no entrance exam options, removing some common barriers and expediting entry into nursing education.

If you’re interested in leadership, healthcare administration programs online offer the flexibility to advance your career while balancing work and family commitments. Additionally, registered nurses can accelerate their learning through adn to np programs online, helping them move into advanced practice roles much faster than with traditional degree paths.

With so many accredited online degrees and alternative pathways, aspiring medical professionals have more opportunities than ever to build a rewarding career in healthcare.

Best Scientists Citing John Mendelsohn

Recently Published Articles